Magenta Therapeutics, Inc. Profile Avatar - Palmy Investing

Magenta Therapeutics, Inc.

Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 ant…

Biotechnology
US, Cambridge [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group

Peers Performance

A quick analysis that compared Magenta Therapeutics, Inc. (MGTA) to it's peer group.

Peer Group
CTMX NXTC SPRO NLTX TIL ASMB NUVB Compare Together
Loading...
End of MGTA's Analysis
CIK: - CUSIP: 55910K108 ISIN: US55910K1088 LEI: - UEI: -
Secondary Listings
MGTA has no secondary listings inside our databases.